Post job

Acenda Pharma's revenue is $580,000.

What is Acenda Pharma's revenue?

Acenda Pharma's annual revenue is $580.0K. Zippia's data science team found the following key financial metrics about Acenda Pharma after extensive research and analysis.
  • Acenda Pharma has 25 employees, and the revenue per employee ratio is $23,200.
  • Acenda Pharma peak revenue was $580.0K in 2024.

On this page

Peak revenue
$580,000 (2025)
Company peak revenue
Revenue / employee
$23,200
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$580,000 (2025)
Company peak revenue
Revenue / employee
$23,200
Company revenue / employee

Acenda Pharma financing

Acenda Pharma received early financing of $2.0M on 2011-11-21.

SeriesRound sizeDate
Equity$2M11/2011

Acenda Pharma revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Acenda Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Acenda Pharma. The employee data is based on information from people who have self-reported their past or current employments at Acenda Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Acenda Pharma. The data presented on this page does not represent the view of Acenda Pharma and its employees or that of Zippia.

Acenda Pharma may also be known as or be related to Acenda Pharma, Acenda Pharma Inc and Acenda Pharma, Inc.